Navigation Links
Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results
Date:2/28/2011

— Acquisition-related items

(12,339)

12,339

(5)

—Operating income149,522

50,105199,627 Interest expense, net

13,834

(4,476)

(6)

9,358 Other (income), net

(1,454)

—(1,454)Income before income taxes137,142

54,581191,723 Income taxes

31,409

19,925

(7)

51,334Consolidated net income$   105,733

$
34,656$
40,389Less: Net income attributable to noncontrolling interest(12,748)

—(12,748)Net income attributable to Endo Pharmaceuticals Holdings Inc.$
92,985

34,656$
27,641Diluted earnings per share

$  0.77$  1.06Diluted weighted average shares

120,516120,516Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:(1)

To exclude amortization of commercial intangible assets related to marketed products of $30,244 and the impact of inventory step-up recorded as part of acquisition accounting of $4,875.(2)

To exclude certain start-up costs and separation benefits incurred in connection with continued efforts to enhance the company's operations.(3)

To exclude milestone and upfront payments to partners.(4)

To exclude an impairment of other intangible assets.(5)

To exclude acquisition-related costs of $41,231 as well as the impact, under purchase accounting, of a gain recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisition of ($53,570).(6)

To exclude additional interest expense as a result of adopting ASC 470-20 of $4,508 and to exclude amortization of the premium on debt acquired from Indevus of ($32).(7)

To reflect the cash tax savings results from our recent acquisitions and the tax effect of the pre-tax adjustments above at applicable tax rates. Three Mont
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
2. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
3. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
4. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
6. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
7. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
9. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
10. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
11. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013   Polymer Technology Systems, ... Aegis Health Group to integrate the CardioChek ... programs administered by health systems across the country. ... PTS and distributed through Hanson Medical Systems ... HDL cholesterol, LDL cholesterol, triglycerides, and glucose. ...
(Date:6/17/2013)... 2013  Hanger, Inc. (NYSE:  HGR) today announced the ... its senior secured facilities to an aggregate of up ... credit agreement includes a $200 million revolving credit facility ... credit agreement was comprised of a $100 million revolving ... new facility matures on June 17, 2018, and is ...
(Date:6/17/2013)... , June 17, 2013 BioMed Realty Trust, Inc. ... of directors has declared a second quarter 2013 dividend of ... to an annualized dividend of $0.94 per common share. ... 15, 2013 to stockholders of record at the close of ... Realty Trust BioMed Realty delivers optimal real estate ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
(Date:6/18/2013)... (PRWEB) June 18, 2013 Exposed Skin Care ... thousands of acne suffers of all ages finally achieve the ... acne treatment products, this new acne clearing system combines the ... and prevent new acne from forming. , After ... believes these products are some of the most effective available ...
(Date:6/18/2013)... 19, 2013 "What if adding one ... could boost your health and well-being? Well, there is ... Sublime Beauty®. "It is called Skin Brushing ." ... became a lost art. Now, people are rediscovering this ... Brushing, and so do certain health conscious people. Sublime ...
(Date:6/18/2013)... PA, June 19, 2013 Recent studies linking ... of bullying-related suicide among young people, led the ... assemble an expert panel to focus on these ... the complex relationship between youth involvement in bullying ... among youth is a significant public health problem, ...
(Date:6/18/2013)... Parker Waichman LLP, a national law ... by dangerous drugs and medical devices, has filed a ... that she was injured by transvaginal mesh ... the U.S. District Court for the Southern District of ... litigation entitled In Re: American Medical Systems, Inc., Pelvic ...
(Date:6/18/2013)... Fla. (PRWEB) June 19, 2013 An ... When Linda Christina Beauregard was diagnosed with breast cancer, ... In her new book, “I Gave Myself Cancer, I ... Life” (published by Balboa Press), Beauregard explains how changing ... cancer. , "Sick people have been made to feel ...
Breaking Medicine News(10 mins):Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:Bullying and suicide among youth is a public health problem 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2
... Department of Orthopaedic Surgery at the University of Pittsburgh School of ... Center (UPMC) for Sports Medicine will be installed as the 37th ... Saturday, July 12, 2008, during the Society,s Annual Meeting in Orlando, ... ...
... NASHVILLE, Tenn., July 2 Ambulatory Services of,America, ... Dallas, LLP, its,sixth joint venture to provide outpatient ... joint venture between ASA,s subsidiary, Radiation,Oncology Services of ... Landmark,Radiation Dallas LP. ROSA of North Dallas will ...
... Senate, derailing a critical bipartisan bill that would have ... to physicians who,treat Medicare patients, and made significant improvements ... Last week, Sen. Richard Lugar joined a minority of ... people on Medicare continued,access to their doctors and improved ...
... childbirth as most common reason for hospitalizations, analysis finds ... more than 1.2 million Americans -- roughly equivalent to ... a federal government analysis of hospital admissions and costs ... the most common reason for admission to hospital, and ...
... company with an outstanding track record in the ... technologies, announced availability of the Genomatix Genome Analyzer ... first integrated hardware / software solution for in-depth ... (NGS) devices as provided by Illumina, Roche (454), ...
... simplex out of hiding could bring about a cure, scientists ... Americans are afflicted by breakouts of unsightly cold sores, caused ... finally offering them the possibility of a cure. , Scientists ... herpes simplex 1 slips into dormancy and stays dormant -- ...
Cached Medicine News:Health News:Reknowned Orthopaedic Surgeon to be Installed as President of Sports Medicine Society 2Health News:Reknowned Orthopaedic Surgeon to be Installed as President of Sports Medicine Society 3Health News:Reknowned Orthopaedic Surgeon to be Installed as President of Sports Medicine Society 4Health News:Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas 2Health News:Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors' Access to Doctors and Improve Medicare 2Health News:Indiana State Medical Association and AARP Urge Reconsideration of Bill to Protect Seniors' Access to Doctors and Improve Medicare 3Health News:Next generation data analysis for next generation sequencing data 2Health News:New Hope Against the Cold Sore Virus 2Health News:New Hope Against the Cold Sore Virus 3
... establish the patient reportable range and establish ... Linearity is available in five-vial sets with ... 3700 and 4000; Bayer ADVIA 120; Coulter ... 755; Sysmex R-3000, R-3500, R-1000, RAM-1, XE-2100 ...
... CVA for CELL-DYN are assayed linearity control ... and to verify patient reportable range of ... also measure the linear performance of the ... have customized ranges appropriate for each instrument ...
... red blood cell (nRBC) control for evaluating the ... 755 hematology analyzer in its enumeration of the ... LH 750/LH 755. nRBC-Chex for LH is a ... for LH has a 75-day closed-vial stability and ...
... Sickle-Chex is a positive and negative whole ... of Hemoglobin S in solubility tests and ... SICKLEDEX and other manufacturers' solubility kits. ... squeeze dropper vial. The vial dispenses an ...
Medicine Products: